International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2

Author(s): Allen Loyd V

Issue: Jul/Aug 2015 - Volume 19, Number 4
View All Articles in Issue

Page(s): 280-287

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 1

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 2

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 3

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 4

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 5

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 6

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 7

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Page 8

Download in electronic PDF format for $75

Abstract: This article, which represents part 2 of a two-part article, completes the discussion on the rapidly changing world of pharmaceuticals as biotechnology continues to grow and nanotechnology appears on the horizon.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, biotechnology, quality control, packaging, storage, labeling, stability, patient counseling, nanotechnology, nanomedicine, nanopharmacy, nanoparticles, pharmacogenomics, personalized medicine, individualized therapy, customized drug therapy, personalization, individualization, customization, drug-metabolizing enzymes, adverse effects, side effects, patient response, drug transport, drug metabolism, target receptors, genes, genetic polymorphism, targeted agents, drug delivery systems

Related Categories: PACKAGING, STABILITIES, COMPATIBILITIES, TECHNOLOGY, QUALITY CONTROL, PATIENT EDUCATION, STORAGE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Allen Loyd V	Jul/Aug 2015 Pg. 280-287
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Allen Loyd V Jr	Jan/Feb 2015 Pg. 38-40
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding with Biotechnology Products, Part 1: General Considerations Allen Loyd V Jr	Sep/Oct 2022 Pg. 385-395
Compounding with Biotechnology Products, Part 2: Product-specific Considerations Allen Loyd V Jr	Nov/Dec 2022 Pg. 446-466
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding Kupiec Thomas C, Okeke Claudia, Allen Loyd V Jr, Denison Clay	Jul/Aug 2005 Pg. 300-302
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Allen Loyd V Jr	May/Jun 2013 Pg. 210-219
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous Allen Loyd V Jr	Nov/Dec 2014 Pg. 486-488
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr	Nov/Dec 2016 Pg. 495-500
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Allen Loyd V Jr, Okeke Claudia C	Mar/Apr 2008 Pg. 136-144
Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids Allen Loyd V Jr	Nov/Dec 2003 Pg. 477-480
Nanotechnology: The Ultimate Alchemy Allen Loyd V Jr	Nov/Dec 2001 Pg. 424-425
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education McElhiney Linda F	May/Jun 2009 Pg. 224-229
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Allen Loyd V Jr, Okeke Claudia C	May/Jun 2009 Pg. 234-238
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging Allen Loyd V Jr	Sep/Oct 2012 Pg. 405-414
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 Allen Loyd V Jr	Mar/Apr 2012 Pg. 146-150
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr	Jul/Aug 2021 Pg. 311-317
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Okeke Claudia C, Allen Loyd V Jr	May/Jun 2010 Pg. 232-238
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Okeke Claudia C, Allen Loyd V Jr	Jul/Aug 2010 Pg. 328-331
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Allen Loyd V Jr	Jan/Feb 2022 Pg. 34-38
Return to Top